image
Healthcare - Biotechnology - NASDAQ - GB
$ 3.08
2.33 %
$ 896 M
Market Cap
-2.7
P/E
CASH FLOW STATEMENT
-146 M OPERATING CASH FLOW
-29.63%
-11 M INVESTING CASH FLOW
-1.34%
-883 K FINANCING CASH FLOW
-0.39%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Autolus Therapeutics plc
image
Net Income -208 M
Depreciation & Amortization 6.56 M
Capital Expenditures -11 M
Stock-Based Compensation 11.2 M
Change in Working Capital 292 K
Others 46.5 M
Free Cash Flow -157 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015
OPERATING CASH FLOW
Net Income (208.4) (148.8) (142.1) (142.1) (123.8) (31.1) (19.7) (12.6) (7.5)
Depreciation & Amortization 6.6 7.4 8.5 5.7 4.6 1.1 1.0 0.5 3.6
Deferred Income Tax (1.0) (0.3) 72 K (1.3) (0.4) (5.2) 0 0 0
Stock Based Compensation 11.2 12.0 9.9 20.1 30.2 5.0 3.2 2.3 0
Other Operating Activities 45.7 13.4 1.8 (1.5) 4.1 (1.1) 5.2 1.2 0.9
Change in Working Capital 0.3 4.0 4.1 1.4 (16.2) 5.4 (0.8) (1.2) (0.4)
Cash From Operations (145.6) (112.3) (117.9) (117.8) (101.5) (25.8) (16.4) (9.8) (3.3)
INVESTING CASH FLOW
Capital Expenditures (11.0) (10.8) (8.9) (14.7) (18.7) (8.8) (2.9) (1.9) (0.8)
Other Items 0 0 0 0 0 1.1 0 0 7.92 K
Cash From Investing Activities (11.0) (10.8) (8.9) (14.7) (18.7) (7.6) (2.9) (1.9) (0.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 (3.2) 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.9) 59.8 38.2 (5.3) (7.1) 156.9 127.7 32.2 12.2
Cash From Financing Activities (0.9) 223.6 284.1 74.4 108.9 117.5 127.7 32.2 12.2
CHANGE IN CASH
Net Change In Cash (142.4) 72.1 156.6 (57.3) (6.1) 87.0 109.0 17.9 8.1
FREE CASH FLOW
Free Cash Flow (156.6) (123.1) (126.7) (132.4) (120.2) (34.6) (19.2) (11.7) (4.1)